Convatec Group Posts Mixed FY25 Results: Profit Dips Yet Dividend Soars on Strong Market Outlook

GasFeeLover · 2026-03-04T05:06:15+00:00

Convatec Group PLC reported its FY2025 results, showing a decline in pre-tax profit despite improved adjusted metrics. The company remains optimistic with a raised dividend, forecasting double-digit earnings growth and enhanced medium-term revenue expectations.

GasFeeLover

2026-03-04 05:06:15

Abstract generation in progress

Convatec Group PLC, a leading medical products and technologies company, recently announced its fiscal 2025 full-year results, revealing a complex financial picture with earnings pressures offset by operational strength and strategic optimism. While pre-tax profit declined to $230 million from $246 million in the prior year, the company’s decision to significantly raise its dividend underscores management confidence in the group’s trajectory and market outlook.

Financial Performance: Adjusted Metrics Tell a Stronger Story

The headline profit decline masks a more encouraging underlying performance. Adjusted pre-tax profit surged to $471 million, up from $411 million previously, reflecting the group’s operational efficiency gains. Adjusted earnings per share climbed to 17.6 cents from 15.2 cents, demonstrating the genuine earning power beneath surface-level figures. Revenue growth remained solid, advancing 6.5 percent to $2.44 billion, or 5.0 percent in constant currency terms. Excluding the InnovaMatrix product line, organic revenue growth reached 6.4 percent—a testament to the core business momentum.

Dividend Decision Affirms Shareholder Value Commitment

The Board recommended a final dividend of 5.367 cents per share, bringing the full-year payout to 7.244 cents—a 13 percent year-over-year increase. This meaningful raise signals management’s conviction regarding the group’s financial stability and future earning potential, even amid near-term profitability headwinds.

Forward Guidance: FY26 Stability and Strengthened Medium-Term Outlook

For fiscal 2026, Convatec Group maintains its expectation of double-digit adjusted earnings per share growth, with organic revenue growth (excluding InnovaMatrix) projected at 5-7 percent, weighted toward the second half. The company targets adjusted Group operating margins in line with or above 23 percent.

Looking further ahead, the company elevated its medium-term outlook for organic revenue growth to 6-8 percent from 2027 onward, up from the previously guided 5-7 percent range. Additionally, Convatec projects sustainable double-digit adjusted annual earnings per share growth and adjusted operating margins of 24-26 percent by 2027—a compelling vision that reaffirms management’s strategic direction and confidence in the group’s long-term value creation potential.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.